Singapore: Trendlines Group to exit portfolio firm BioSight for $1.3m

Singapore: Trendlines Group to exit portfolio firm BioSight for $1.3m

Steve Rhodes & Todd Dollinger, co-founders of Trendlines

Shiwen Yap

06 June, 2017

Arkin Bio VenturesBiosight LimitedManagement Services LtdMisgav/Karmiel Technology IncubatorTrendlines Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.